Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2018.04.04
关于购置资产暨关联生意的希望通告
2018.03.29
2018年度第一季度业绩预告
2018.03.06
2018年第二次暂时股东大会的执法意见书
2018.03.06
2018年第二次暂时股东大会决议通告
2018.03.03
关于公司和全资孙公司配合对外投资完成的通告
2018.02.27
2017年度业绩快报
2018.02.13
关于召开2018年第二次暂时股东大会通知的更正通告
2018.02.13
华融证券股份有限公司关于公司果真刊行2016年公司债券重大事项受托治理事务暂时报告
2018.02.12
关于公司与Aridis设立合资子公司的通告
2018.02.12
关于2018年过活常谋划性关联生意预计的通告
第一页
上一页
56
57
58
59
60
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】